| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |